Extracellular vesicles as the “magic bullet” for fighting threats to humanity

Abstract

Many researchers worldwide are currently trying to develop targeted molecular therapies such as nucleic acid medicines or antibody-drug conjugates for various diseases. Writing in Extracellular Vesicles and Circulating Nucleic Acids, Kim et al. summarized existing technologies for encapsulating therapeutic molecules into exosomes and introduced some human cell lines which are able to produce safe, effective therapeutic exosomes. Their review article offers the “magic bullet” for fighting threats to humanity such as the current coronavirus pandemic.

Keywords

Extracellular vesicles / therapeutic exosomes / drug delivery system / COVID-19

References

[1] Tan SY.Paul Ehrlich (1854-1915): man with the magic bullet.Singapore Med J2010;51:842-3

[2] Valadi H,Bossios A,Lee JJ.Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.Nat Cell Biol2007;9:654-9

[3] Ratajczak J,Kucia M.Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery.Leukemia2006;20:847-56

[4] Kosaka N,Yoshioka Y,Matsuki Y.Secretory mechanisms and intercellular transfer of microRNAs in living cells.J Biol Chem2010;285:17442-52 PMCID:PMC2878508

[5] Pegtel DM,Thorley-Lawson DA.Functional delivery of viral miRNAs via exosomes.Proc Natl Acad Sci U S A2010;107:6328-33 PMCID:PMC2851954

[6] Zhang Y,Chen X.Secreted monocytic miR-150 enhances targeted endothelial cell migration.Mol Cell2010;39:133-44

[7] Zomer A,Verweij FJ.In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior.Cell2015;161:1046-57 PMCID:PMC4448148

[8] Hoshino A,Shen TL.Tumour exosome integrins determine organotropic metastasis.Nature2015;527:329-35 PMCID:PMC4788391

[9] Yim N,Choi K.Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module.Nat Commun2016;7:12277 PMCID:PMC4961865

[10] Kim J,Park CH.Platform technologies and human cell lines for the production of therapeutic exosomes.Extracell Vesicles Circ Nucleic Acids2021;2:3-17

[11] Samuel M,Liem M.Bovine milk-derived exosomes from colostrum are enriched with proteins implicated in immune response and growth.Sci Rep2017;7:5933 PMCID:PMC5517456

[12] Somiya M,Ochiya T.Biocompatibility of highly purified bovine milk-derived extracellular vesicles.J Extracell Vesicles2018;7:1440132 PMCID:PMC5827637

[13] Munagala R,Jeyabalan J.Exosomal formulation of anthocyanidins against multiple cancer types.Cancer Lett2017;393:94-102 PMCID:PMC5837866

[14] Umezu T,Murakami Y.Acerola exosome-like nanovesicles to systemically deliver nucleic acid medicine via oral administration.Mol Ther Methods Clin Dev2021;21:199-208 PMCID:PMC8010214

[15] Sengupta V,Lazo A,Nolan A.Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19.Stem Cells Dev2020;29:747-54 PMCID:PMC7310206

[16] Jamalkhah M,Azangou-Khyavy M.MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak.J Transl Med2021;19:164 PMCID:PMC8061879

[17] Théry C,Aikawa E.Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.J Extracell Vesicles2018;7:1535750 PMCID:PMC6322352

[18] Börger V,Anderson JD.International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19.Cytotherapy2020;22:482-5 PMCID:PMC7229942